Then, we examined the levels of c-Myc protein in three MM cell lines after anlotinib treatment, and the results showed that anlotinib dramatically down-regulated c-Myc in a dose- and time-dependent manner without effect on its mRNA levels (Figs. 4E and S3). This evidence concerns the gene MYC and Miyoshi myopathy.